Era of Precision Oncology for Prostate Cancer ‘Is Upon Us’
July 10, 2016 Bryant Furlow [ultimate_spacer height=”32″]Full Article[ultimate_spacer height=”32″] New biomarkers might revolutionize prostate cancer treatment, according to an educational presentation at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.1“We are now entering an era of personalized prostate cancer therapy informed by treatment-specific biomarkers, some of which can be performed using a…